For Physicians For Patients
Text Size: A A A
Facebook LinkedIn Twitter

Find a Provider

American Health Network


For more information, please call us at 317-718-5482 or 877-340-7291.

DIABETES - Be part of the Future in Diabetes Research


The purpose of the Carmelina Study is to look at the impact of an investigational drug called linagliptin on the long-term occurrence of selected complications of cardiovascular disease (e.g. stroke or heart attack) in people with type 2 diabetes receiving standard of care

You may be eligible to take part in the Carmelina Study if:

  • You are 18 years of age or older
  • You have been diagnosed with type 2 diabetes
  • You have been receiving a stable dose of antidiabetic medication for at least 8 weeks or you have not previously received antidiabetic treatment
  • You have previously had problems with your heart (cardiovascular disease) and/or kidneys (renal disease)


You may be eligible to participate in this study if you:

  • Are 40 years of age or older. Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.
  • Have been diagnosed with type 2 diabetes
  • Have established cardiovascular disease with at least one of the following: coronary artery disease, cerebrovascular disease, or peripheral arterial disease.

Merck Type 2 Diabetes and Renal Insufficiency

The Merck Type 2 Diabetes Study is evaluating the safety and effectiveness of two investigational study medications for type 2 diabetes.

Who is eligible for the Merck Type 2 Diabetes Study?

This study will enroll 556 adults from around the world. You may be eligible to participate if you:

  • Are at least 25 years of age
  • Have been diagnosed with type 2 diabetes
  • Have mild renal impairment with an eGFR ≥ 60 mL/min/1.73m² and <90 mL/min/1.73m²
  • Are willing to participate in the study for approximately 30 weeks

Merck Type 2 Diabetes

We are conducting a study to research to research the effectiveness and safety of an investigational study drug for type 2 diabetes in adults 21-65 years old. If you are taking only metformin for your diabetes, and do not use nicotine or nicotine containing products, you might qualify to participate in this study.

Participants may receive:

  • Study-related care for type 2 diabetes
  • Study medication (my include inactive placebo)
  • Glucose meter and testing supplies

Achieve Control Study

Has your doctor recommended that you begin taking insulin to control your diabetes?

If so, you may want to consider participating in Achieve Control……

Achieve Control is a real-world study sponsored by Sanofi and will include patients who are starting insulin for the first time. The study will evaluate how well patient reach their HbA1C targets using one of the marketed basal insulin without experiencing symptoms of low blood sugar such as dizziness etc.

You may be eligible if ……

  • You have Type 2 diabetes
  • You have used 2 or more anti-diabetes medications for at least 1 year
  • You have never used insulin ( except for temporary use during hospitalization or pregnancy)

Your participation in this study is voluntary and will last up to 12 months if you complete the study. The cost for the insulin and supplies will be provided by the study sponsor.


Are you tired of daily injections to control your type 2 diabetes?

This is a clinical research study looking at a potential new treatment approach for people with type 2 diabetes. The approach uses a small investigational device to release exenatide, the active ingredient in another approved medication, to help control your blood sugar levels over a period of up to 6 months, without the need for daily liraglutide (also known as Victoza®) injections.

Can you take part in the FREEDOM-3S Study?

You may be eligible to take part if you:

  • Are 18-80 years of age
  • Have been diagnosed with type 2 diabetes for at least 3 months
  • Have been taking liraglutide and metformin every day for at least 3 months

DS8500-A-U202 Diabetic Trial

The DS8500-A-U202 Study is a clinical research study looking at safety and effectiveness of a potential new treatment option for people with type 2 diabetes who are receiving metformin.

You may be able to take part in the study if you:

  • Are aged between 18 and 70 years, inclusive
  • Have been diagnosed with T2DM
  • Have been taking metformin (at least 1000mg/day) for at least 8 weeks

If you are eligible and choose to take part, you will be in the study for up to 18 weeks and will have about 8 visits at the study center. There will be no cost to you to participate.



If you currently have an abnormal lipid profile, you may qualify to participate in a clinical research study. To qualify, you must be at least 18 years of age, have triglyceride levels between 200 and 500 mg/dL, and meet other eligibility criteria. Study-related exams and medication/placebo may be provided to qualified participants.


COPD Trial

If you are living with moderate-to-severe COPD, you may qualify for a new clinical research study. The study is for an investigational medication that may help improve COPD symptoms.

You may be able to take part in the study if you:

  • At least 40 years old
  • Current or former smoker
  • Have been diagnosed with COPD, emphysema, or chronic bronchitis
  • Use oxygen no more than 15 hours per day
  • Able to attend required study visits


Birth Control Ring

Clinical Research doctors are studying an investigational vaginal ring for birth control. Doctors are conducting this study to evaluate whether the investigational vaginal ring is safe and effective.

Do I qualify?

The study staff will determine if you are eligible to participate. At a minimum, you must meet the following criteria:

  • Are a woman 18 years of age or older
  • Are heterosexually active and at risk for pregnancy
  • Must agree to avoid other forms of birth control while participating in the study


Milestone Stroke

The Milestone study is looking at the safety and effectiveness of a potential new medication for the treatment of walking problems in people who have had a stroke.

You may be able to take part if you:

  • Are 18 years of age or older
  • Have had an ischemic stroke
  • Have walking problems as a result of the ischemic stroke

The study will last about 5 months and will involve approximately 10 visits to a study center.

All study-related visits, assessments, and study medication will be provided at no cost to you. In addition, compensation for time and travel may be provided.


Foot Ulcer

Are you a diabetic? Do you have a sore on your foot?

A foot ulcer is an open sore on the foot that can be difficult to heal. You may qualify to participate in a clinical research study of an investigational product.

Qualified participants may receive study-related:

  • Evaluations, physical exams, routine lab work
  • Investigational product or placebo
  • Wound care dressings

Compensation for time and travel may be available.

Flu Trial

If you’ve had flu symptoms for less than 5 days, consider our study on a new investigational flu treatment.

Our clinic is looking for volunteers to test a new investigational study medication for people with influenza (flu). To participate you must:

  • Be 18 to 65 years old
  • Have flu symptoms that began within the last 5 days (including fever, aches, chills, cough, nasal congestion, sore throat, headache, or fatigue
  • Have not taken flu medicines like Tamiflu, Relenza, or Rapivab in the past 2 weeks

Your medical history and other criteria will be reviewed at the first study visit to see if you can be in the study.

The main part of the study includes 4 visits to the study clinic over 7 days and 6 scheduled telephone calls over the next 3 months. Qualified participants will receive study medication at no cost.

© Copyright 2017 AHN Target Holdings, LLC. All Rights Reserved.